Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Compugen
discovers cancer drug target 6:50 AM 12/28/2009
Reuters
Compugen Ltd talks up their compound CGEN-671 for the treatment of multiple epithelial
tumors.
...
Venture
Firms Jump Back Into Antibiotics, With Winning Results 5:43 AM 12/28/2009
Wall Street Journal
Cubist Pharmaceuticals buying Calixa Therapeutics Inc
is a sign of venture capital returning to this segment.
...
German
Merck sees chemical, pharma acquisitions 12:38 PM 12/27/2009
Reuters
Merck KGaA has mulled acquisitions in both the pharmaceutical and chemical sectors
with enough funds to finance small or big acquisitions.
...
Righting
a Wrong, Much Too Late 7:10 AM 12/26/2009
New York Times
Clean syringes and drug treatment programs. Needle exchange programs managed to
cut the infection rates among addicts by about 80 percent.
...
GOP
Lawmakers Change Tune on Costly Health Plans 5:50 AM 12/26/2009
ABC News
It's just another power grab. There were no new taxes or spending offsets when
Republicans voted in the Medicare drug benefits in 2003. They now criticize Democrats for adding to the
national debt.
...
Experimental
Pfizer drug may help rare bone cancer 5:13 PM 12/23/2009
Reuters
An early study of Pfizer's experimental drug figitumumab found it helped fight the
rare bone cancer Ewing's sarcoma.
...
Health
stock rally may extend as reform winds down 1:33 PM 12/23/2009
Reuters
Mid-cap biotech stocks and large pharmaceutical stocks are two groups that
could rise at least 10 percent over the next month as legislation currently leaves both industries unscathed.
...
pSivida's
eye drug shows promise in study, shares surge 12:23 PM 12/23/2009
Reuters
pSivida Corp reported mixed results for its experimental eye drug
Iluvien.
...
Lilly,
Kowa in promotion deal for new statin drug 12:11 PM 12/23/2009
Reuters
Eli Lilly and Co has entered a co-promotion agreement with privately held Kowa
Co Ltd of Japan to help commercialize Livalo.
...
Novartis
invests $120 mln to secure new heart drug 6:10 AM 12/23/2009
Reuters
Novartis agreed to buy privately held Cothera for $120 million to gain
exclusive rights to relaxin currently in late-stage clinical trials.
...
Drug
Industry Girds for Rise in Its Share of Overhaul 5:50 AM 12/23/2009
New York Times
President Obama and the Senate Finance Committee struck a deal to
cap industry costs at $80 billion. Liberals lost on so many fronts that drug makers may have to renegotiate
bringing the cap closer to $100 billion.
...
MorphoSys
eyes targets to widen drug pipeline-paper 3:35 AM 12/23/2009
Reuters
German biotech Morphosys is looking for takeover targets to expand its range of
experimental drugs.
...
Amgen
wins anemia drug patent dispute with Roche 3:07 PM 12/22/2009
Reuters
A US court ruled that Roche Holding's anemia drug Mircera infringes Amgen
Inc patents and entered a permanent injunction against selling Mircera in the US.
...
US
FDA: Merck's Vytorin unlikely to increase cancer 12:23 PM 12/22/2009
Reuters
The US FDA believes it unlikely that Vytorin or Zetia increase the risk
of cancer or cancer-related death.
...
Arena
files for approval for weight loss drug 8:15 AM 12/22/2009
Reuters
Arena Pharmaceuticals Inc has submitted an application with the US FDA to
market its experimental weight loss drug lorcaserin.
...
<- Day Earlier | Today's News
|
